Metacognitive training for older adults with depression
Metacognitive Training in the Older Adults With Depressive Symptoms
This study is testing a new group program to help older adults with depression by changing negative thinking patterns to see if it can improve their mood.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 60 Years to 105 Years |
| Sex | All |
| Sponsor | University of Évora Academic / other |
| Locations | 1 site (Évora) |
| Trial ID | NCT05640492 on ClinicalTrials.gov |
What this trial studies
This project focuses on a group intervention called Metacognitive Training for Depression in Later Life (MCT-Silver) designed to help older adults with depressive symptoms. The intervention aims to challenge and correct dysfunctional thinking patterns through a structured program over 4 to 8 weeks. It will be culturally adapted for Portugal and assessed through a pilot study and a Randomized Controlled Trial (RCT) to evaluate its efficacy. The study seeks to provide a non-pharmacological approach to managing depression in older adults.
Who should consider this trial
Good fit: Ideal candidates are older adults aged 60 and above who are experiencing depressive symptoms and can communicate in Portuguese.
Not a fit: Patients with active psychotic symptoms, acute suicidal ideation, or significant cognitive impairment may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce depressive symptoms in older adults, improving their quality of life.
How similar studies have performed: Previous studies have shown positive results for similar metacognitive training approaches, indicating potential for success in this adaptation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ability to give informed consent * Age: 60 years or older * Sufficient command of the Portuguese language * Willingness to participate in the intervention for a period of 4 to 8 weeks (participants who do not participate in the intervention will also be included in the analysis) * Adequate visual and hearing acuity for neuropsychological testing and participation in the group sessions * Values above 10 on the Hamilton Depression Scale Exclusion Criteria: * Active psychotic symptoms (i.e., hallucinations, delusions, or manias) * Acute suicidal ideation * Cognitive impairment * Dementia or other neurological disease
Where this trial is running
Évora
- Lara Manuela Guedes de Pinho — Évora, Portugal (Recruiting)
Study contacts
- Study coordinator: Lara Pinho, PhD
- Email: lmgp@uevora.pt
- Phone: 00351266740800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.